Limited Coverage Drugs - Dipyridamole-acetylsalicylic acid

Generic Name / Strength / Form
Dipyridamole-acetylsalicylic acid

Criteria Approval Period
For secondary prevention of cerebrovascular occlusion and embolization in patients who have experienced recurrent TIA or stroke while receiving ASA alone. Indefinite

Practitioner Exemptions

  • None

Special Notes

  • None

Special Authority Request Forms